Raphael J. Landovitz

机构：APLA Health, University of California, Los Angeles · ORCID：0000-0002-1442-714X

发表论文 215 篇 · 总被引 9153 次 · h-index 42

代表论文

• Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel (2024 · JAMA · 被引 250)
• Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084 (2025 · Journal of the International AIDS Society · 被引 18)
• Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial (2024 · The Lancet HIV · 被引 12)
• Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection (2025 · JCI Insight · 被引 11)
• Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data (2025 · JAMA Network Open · 被引 6)
• Preexposure Prophylaxis for HIV (2025 · JAMA · 被引 5)